Literature DB >> 28544755

A gene-based review of RGS4 as a putative risk gene for psychiatric illness.

Emanuel Schwarz1.   

Abstract

Considerable efforts have been made to characterize RGS4 as a potential candidate gene for schizophrenia. Investigations span across numerous modalities and include explorations of genetic risk associations, mRNA and protein levels in the brain, and functionally relevant interactions with other candidate genes as well as links to schizophrenia relevant neural phenotypes. While these lines of investigations have yielded partially inconsistent findings, they provide a perspective on RGS4 as an important part of a larger biological system contributing to schizophrenia risk. This gene-based review aims to provide a comprehensive overview of published data from different experimental modalities and discusses the current knowledge of RGS4's systems-biological impact on the schizophrenia pathology.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  GWAS; RGS4; expression; schizophrenia

Mesh:

Substances:

Year:  2017        PMID: 28544755     DOI: 10.1002/ajmg.b.32547

Source DB:  PubMed          Journal:  Am J Med Genet B Neuropsychiatr Genet        ISSN: 1552-4841            Impact factor:   3.568


  5 in total

1.  The Antipsychotic Drug Clozapine Suppresses the RGS4 Polyubiquitylation and Proteasomal Degradation Mediated by the Arg/N-Degron Pathway.

Authors:  Jun Hyoung Jeon; Tae Rim Oh; Seoyoung Park; Sunghoo Huh; Ji Hyeon Kim; Binh Khanh Mai; Jung Hoon Lee; Se Hyun Kim; Min Jae Lee
Journal:  Neurotherapeutics       Date:  2021-04-21       Impact factor: 6.088

2.  Dysregulation of a specific immune-related network of genes biologically defines a subset of schizophrenia.

Authors:  Svenja V Trossbach; Laura Hecher; David Schafflick; René Deenen; Ovidiu Popa; Tobias Lautwein; Sarah Tschirner; Karl Köhrer; Karin Fehsel; Irina Papazova; Berend Malchow; Alkomiet Hasan; Georg Winterer; Andrea Schmitt; Gerd Meyer Zu Hörste; Peter Falkai; Carsten Korth
Journal:  Transl Psychiatry       Date:  2019-05-31       Impact factor: 6.222

3.  Prenatal interleukin 6 elevation increases glutamatergic synapse density and disrupts hippocampal connectivity in offspring.

Authors:  Filippo Mirabella; Genni Desiato; Sara Mancinelli; Giuliana Fossati; Marco Rasile; Raffaella Morini; Marija Markicevic; Christina Grimm; Clara Amegandjin; Alberto Termanini; Clelia Peano; Paolo Kunderfranco; Graziella di Cristo; Valerio Zerbi; Elisabetta Menna; Simona Lodato; Michela Matteoli; Davide Pozzi
Journal:  Immunity       Date:  2021-11-09       Impact factor: 31.745

4.  Short stature and combined immunodeficiency associated with mutations in RGS10.

Authors:  Ivan K Chinn; Zhihui Xie; Eunice C Chan; Bianca M Nagata; Alexey Koval; Wei-Sheng Chen; Fan Zhang; Sundar Ganesan; Diana N Hong; Motoshi Suzuki; Glenn Nardone; Ian N Moore; Vladimir L Katanaev; Andrea E Balazs; Chengyu Liu; James R Lupski; Jordan S Orange; Kirk M Druey
Journal:  Sci Signal       Date:  2021-07-27       Impact factor: 9.517

5.  Association between RGS4 gene polymorphisms and schizophrenia: A protocol for systematic review and meta-analysis.

Authors:  Feng-Ling Xu; Jun Yao; Bao-Jie Wang
Journal:  Medicine (Baltimore)       Date:  2021-11-05       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.